sidebar - Data rooms are used all the time for mergers and acquisitions. There are confidentiality agreements restricting the use of the information. I have never read one but I would assume that along with disclosing the information to other parties, there would also be a restriction barring those privy to the information from trading in the open market. That would restrict, say a pharma suitor, to only using the information to decide whether or not to make a bid and at what price. This is common practice and would make deals fairly impossible without them. 

"Much of the information released will be confidential and restrictions should be applied to the viewers' ability to release this to third parties by forwarding, copying or printing."